Trade Summary

5 days ago, Reich Kristian, serving as Chief Scientific Officer at MoonLake Immunotherapeutics (MLTX), sold 52,448 shares at $20.02 per share, for a total transaction value of $1,049,960.00. Following this transaction, Reich Kristian now holds 2,712,298 shares of MLTX.

This sale represents a 1.90% decrease in Reich Kristian's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Tuesday, July 21, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, July 23, 2026 at 4:05 PM ET, 2 days after the trade was made.

MoonLake Immunotherapeutics operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.